Arielle Thal

Arielle Thal

Auto-generated profile, based on publicly available information

Arielle Thal

Department of Otolaryngology – Head & Neck Surgery Thomas Jefferson University Hospitals Philadelphia Pennsylvania USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
ATArielle Thal
Arielle Thal
ALAndrew Lee
Andrew Lee
HMHoward S. Moskowitz
Howard S. Moskowitz

7 January 2026 in Microsurgery
Verified
Journal Article
Closed access
AAAngela Alnemri
Angela Alnemri
AMAnnie Moroco
Annie Moroco
NGNeha Garg
Neha Garg
KBKelly Bridgham
Kelly Bridgham
MDMatt Davis
Matt Davis
RHRyan Heffelfinger
Ryan Heffelfinger

31 January 2022 in Journal of Patient Safety
Verified
Journal Article
Open access
ATArielle G. Thal
Arielle G. Thal
SASadia Ba Ahmed
Sadia Ba Ahmed
SKStanley Bs Kim
Stanley Bs Kim
CYChristina J. Yang
Christina J. Yang
QGQi Gao
Qi Gao
VMVikas Mehta
Vikas Mehta
Objective: A lack of guidance for pain control after otolaryngology surgery can lead to overprescription of opioids. We implemented a postoperative site-specific opioid prescription protocol and analyzed the impact on opioid prescriptions. Methods: This is a retrospective cohort study. A postoperative opioid prescription protocol was implemented within our otolaryngology department at a tertiary academic medical center on January 1, 2020. Retrospective chart review was completed for all patients undergoing otolaryngology surgery from November 1, 2019, to February 29, 2020 (2 months before and after initiation of intervention; n = 1070). The primary outcome was change in the amount of opioid prescribed for the preintervention and postintervention cohorts. Unplanned contact related to pain and opioid refills were tracked to assess pain control. Results: A total of 940 cases were included; adult and pediatric data were analyzed separately. There were 489 pediatric cases, 250 preintervention and 239 postintervention. There was a significant decrease in the amount of opioid prescribed per pediatric patient in the postintervention cohort (2.7 versus 0.32 morphine milligram equivalents, P = 0.02), and 99% of patients were not prescribed opioids at all. There was no significant change in unplanned contact, and no refills were required. There were 451 adult cases, 200 preintervention and 251 postintervention. There was no statistically significant decrease in the amount of opioid prescribed per adult patient (56.8 versus 51.7 morphine milligram equivalents, P = 0.23). There was no significant increase in unplanned contact or refills. Conclusions: A postoperative opioid prescribing protocol can reduce the amount of opioid prescribed without increasing unplanned contact or opioid refills.

25 November 2025 in Head & Neck
Verified
Journal Article
Closed access
KBKelly Bridgham
Kelly Bridgham
TDTeresa Duong
Teresa Duong
PKPraneet Kaki
Praneet Kaki
TATyler Allcroft
Tyler Allcroft
KLKalena Liu
Kalena Liu
JCJoseph Curry
Joseph Curry

16 March 2021 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
YAYasmina Ahmed
Yasmina Ahmed
ACAngela Cao
Angela Cao
ATArielle Thal
Arielle Thal
SSSharan Shah
Sharan Shah
VMVikas Mehta
Vikas Mehta
BSBradley A. Schiff
Bradley A. Schiff

19 January 2026 in Oral Oncology
Verified
Journal Article
Open access
SSSindhura Sridhar
Sindhura Sridhar
AMAnnie Moroco
Annie Moroco
SGShravan Gowrishankar
Shravan Gowrishankar
MMMitra Mehrad
Mitra Mehrad
KEKim Ely
Kim Ely
MTMichael Topf
Michael Topf
Current guidelines for the management of metastatic squamous cell carcinoma of unknown primary (SCCUP) recommend submission of suspicious primary sites for frozen section analysis (FSA). This study aims to investigate the diagnostic accuracy of FSA for identification of HPV-associated SCCUP. A retrospective cohort study of patients with biopsy-proven p16-positive SCCUP who underwent diagnostic operation at two tertiary care institutions was performed. Sensitivity, specificity, PPV, and NPV of diagnostic FSA were assessed. 77 patients were included in analysis. 66 patients underwent definitive TORS (diagnostic TORS operation with subsequent neck dissection after identification of the occult primary tumor), 7 patients underwent diagnostic TORS (TORS to identify occult primary tumor, no neck dissection), and 4 patients underwent direct laryngoscopy and biopsy only. Primary tumors were identified in 63 patients (82%) with a mean tumor size of 1.1 cm. There was no significant difference in size between patients whose tumor was identified on FSA (mean 1.1 cm) and on permanent only (mean 0.9 cm) (p = 0.26). The sensitivity, specificity, PPV, and NPV of FSA for SCCUP was 86%, 100%, 100%, and 86%, respectively. Diagnostic frozen specimens included 52 direct laryngoscopy biopsies and 69 TORS excisions. In the biopsies, sensitivity was 100% and NPV was 100%, whereas in the TORS-excised specimens, sensitivity was 77% and NPV was 77%. In this case series of 77 patients with SCCUP, the sensitivity and NPV of FSA for identification of the primary tumor was over 85%. FSA is valuable during diagnostic operation for SCCUP.